| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
42,013 |
35,226 |
$3.46M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
26,647 |
6,610 |
$2.94M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
26,646 |
6,666 |
$1.96M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24,621 |
22,528 |
$1.92M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,890 |
20,655 |
$1.85M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
13,601 |
3,848 |
$1.07M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,295 |
10,204 |
$947K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
9,954 |
7,825 |
$707K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,077 |
4,918 |
$538K |
| 59025 |
Fetal non-stress test |
11,765 |
8,529 |
$525K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,237 |
7,197 |
$488K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,036 |
2,628 |
$427K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,770 |
4,007 |
$373K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,639 |
5,502 |
$370K |
| 36415 |
Collection of venous blood by venipuncture |
52,443 |
32,753 |
$344K |
| 92526 |
|
8,845 |
2,199 |
$332K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
10,546 |
7,480 |
$307K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,599 |
2,177 |
$287K |
| G0378 |
Hospital observation service, per hour |
5,753 |
4,267 |
$273K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,094 |
4,652 |
$256K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12,823 |
10,454 |
$232K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,014 |
13,246 |
$199K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,077 |
1,037 |
$188K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,969 |
2,505 |
$134K |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,235 |
2,147 |
$131K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,217 |
2,531 |
$124K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,225 |
7,028 |
$119K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,224 |
3,033 |
$100K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27,553 |
18,658 |
$98K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
935 |
797 |
$96K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,286 |
10,716 |
$84K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,684 |
12,299 |
$84K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,388 |
3,065 |
$83K |
| J2704 |
Injection, propofol, 10 mg |
2,930 |
2,389 |
$83K |
| 80053 |
Comprehensive metabolic panel |
15,976 |
12,616 |
$72K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41,012 |
29,801 |
$62K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,586 |
1,170 |
$62K |
| 0225U |
|
616 |
591 |
$58K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,207 |
1,990 |
$55K |
| J7510 |
Prednisolone oral, per 5 mg |
1,051 |
988 |
$53K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,346 |
9,850 |
$52K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,139 |
9,560 |
$48K |
| 82731 |
|
881 |
754 |
$47K |
| 81001 |
|
26,451 |
22,411 |
$47K |
| 81025 |
|
5,486 |
4,877 |
$46K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,245 |
921 |
$42K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,280 |
845 |
$42K |
| 86850 |
|
6,973 |
5,427 |
$42K |
| 97162 |
|
482 |
422 |
$41K |
| 87070 |
|
2,995 |
2,650 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
5,032 |
4,574 |
$37K |
| 85610 |
|
10,276 |
7,468 |
$37K |
| 85730 |
|
9,658 |
7,180 |
$37K |
| 92523 |
|
362 |
339 |
$36K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,306 |
2,596 |
$36K |
| C1769 |
Guide wire |
1,613 |
1,121 |
$36K |
| 76830 |
Ultrasound, transvaginal |
1,430 |
1,274 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
10,922 |
8,855 |
$35K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
888 |
842 |
$29K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,958 |
8,894 |
$28K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,830 |
1,149 |
$27K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,356 |
927 |
$27K |
| 86900 |
|
7,961 |
6,240 |
$27K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,507 |
2,013 |
$25K |
| 82948 |
|
1,897 |
1,362 |
$25K |
| 86901 |
|
8,011 |
6,315 |
$25K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
942 |
826 |
$23K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,778 |
1,919 |
$23K |
| 74018 |
|
1,581 |
1,421 |
$23K |
| 85027 |
|
6,507 |
4,641 |
$22K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,527 |
1,831 |
$22K |
| 87040 |
|
4,518 |
3,609 |
$20K |
| 92610 |
|
313 |
262 |
$18K |
| 97166 |
|
131 |
125 |
$18K |
| 84484 |
|
7,937 |
5,094 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,792 |
1,888 |
$18K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,963 |
10,484 |
$18K |
| 83735 |
|
9,452 |
6,574 |
$18K |
| 87631 |
|
579 |
547 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
260 |
213 |
$16K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
388 |
241 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,141 |
7,487 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,626 |
6,213 |
$13K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
533 |
370 |
$12K |
| 82550 |
|
3,023 |
2,355 |
$11K |
| J1815 |
Injection, insulin, per 5 units |
940 |
558 |
$10K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
266 |
228 |
$10K |
| 94664 |
|
3,446 |
2,987 |
$10K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
141 |
110 |
$10K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,307 |
841 |
$9K |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
280 |
223 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,920 |
1,367 |
$9K |
| 12011 |
|
319 |
284 |
$9K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,179 |
970 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
508 |
464 |
$9K |
| 73630 |
|
865 |
744 |
$9K |
| 87077 |
|
1,951 |
1,571 |
$9K |
| 84100 |
|
2,048 |
1,239 |
$9K |
| 73562 |
|
808 |
685 |
$8K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,991 |
1,605 |
$8K |
| 97163 |
|
54 |
51 |
$8K |
| 80076 |
|
8,943 |
7,383 |
$8K |
| 73610 |
|
693 |
620 |
$8K |
| 93971 |
|
509 |
436 |
$8K |
| 97161 |
|
829 |
603 |
$8K |
| 97165 |
|
462 |
339 |
$7K |
| 82553 |
|
788 |
589 |
$7K |
| 83690 |
|
10,072 |
8,392 |
$7K |
| 76770 |
|
184 |
162 |
$7K |
| 87205 |
|
2,015 |
1,698 |
$7K |
| 74019 |
|
389 |
367 |
$6K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
193 |
163 |
$6K |
| 73130 |
|
341 |
297 |
$6K |
| 83880 |
|
2,351 |
1,869 |
$5K |
| A4402 |
Lubricant, per ounce |
78 |
75 |
$5K |
| 73030 |
|
411 |
324 |
$5K |
| 97168 |
|
33 |
30 |
$5K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
76 |
55 |
$5K |
| 36902 |
|
25 |
14 |
$5K |
| 84112 |
|
164 |
133 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
181 |
150 |
$5K |
| 76937 |
|
135 |
106 |
$5K |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
590 |
466 |
$5K |
| 84702 |
|
5,198 |
3,905 |
$4K |
| 70486 |
|
112 |
99 |
$4K |
| 96367 |
|
565 |
405 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,491 |
2,496 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
84 |
75 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,646 |
1,282 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
559 |
406 |
$4K |
| 84703 |
|
4,228 |
3,632 |
$4K |
| 10060 |
|
111 |
99 |
$4K |
| 73110 |
|
262 |
228 |
$3K |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
87 |
65 |
$3K |
| 87632 |
|
630 |
599 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,998 |
2,535 |
$3K |
| 83986 |
|
53 |
38 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
545 |
157 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
813 |
675 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
619 |
504 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,015 |
1,622 |
$3K |
| 93970 |
|
139 |
120 |
$3K |
| 51701 |
|
1,304 |
1,173 |
$3K |
| 81003 |
|
2,773 |
2,337 |
$2K |
| 71250 |
|
63 |
54 |
$2K |
| 97116 |
|
320 |
197 |
$2K |
| 29125 |
|
254 |
231 |
$2K |
| 87186 |
|
2,146 |
1,767 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,073 |
740 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,082 |
939 |
$2K |
| 86141 |
|
4,405 |
3,911 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
151 |
103 |
$2K |
| 74022 |
|
115 |
102 |
$2K |
| 87807 |
|
3,095 |
2,904 |
$2K |
| 87075 |
|
317 |
240 |
$2K |
| 80061 |
Lipid panel |
413 |
319 |
$2K |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
49 |
41 |
$1K |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
49 |
41 |
$1K |
| 88304 |
|
374 |
312 |
$1K |
| 72100 |
|
160 |
145 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
248 |
161 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,368 |
669 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,074 |
932 |
$1K |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
129 |
108 |
$948.60 |
| 82150 |
|
1,060 |
925 |
$917.64 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
107 |
100 |
$902.43 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
55 |
42 |
$852.43 |
| 76801 |
|
13 |
13 |
$834.08 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
437 |
357 |
$820.37 |
| 59050 |
|
168 |
113 |
$782.67 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
24 |
24 |
$779.37 |
| 96376 |
|
1,660 |
1,084 |
$755.17 |
| 90715 |
|
349 |
290 |
$751.47 |
| A4550 |
Surgical trays |
13 |
13 |
$653.59 |
| 85652 |
|
948 |
805 |
$633.45 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
35 |
25 |
$606.78 |
| 73080 |
|
72 |
65 |
$575.42 |
| 84132 |
|
75 |
55 |
$537.72 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
423 |
293 |
$537.26 |
| C1729 |
Catheter, drainage |
216 |
181 |
$431.75 |
| 97164 |
|
12 |
12 |
$419.17 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
313 |
260 |
$417.48 |
| J0456 |
Injection, azithromycin, 500 mg |
17 |
14 |
$417.48 |
| 83605 |
|
626 |
466 |
$408.63 |
| 85379 |
|
1,246 |
1,082 |
$390.67 |
| 87045 |
|
29 |
28 |
$358.92 |
| 86920 |
|
314 |
207 |
$334.21 |
| 82607 |
|
121 |
88 |
$312.01 |
| 82746 |
|
112 |
82 |
$307.23 |
| A9270 |
Non-covered item or service |
65 |
49 |
$298.95 |
| 86738 |
|
264 |
253 |
$280.36 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
805 |
496 |
$261.32 |
| 82270 |
|
15 |
12 |
$235.77 |
| 31720 |
|
81 |
68 |
$231.97 |
| 73502 |
|
15 |
12 |
$224.32 |
| 29515 |
|
16 |
13 |
$189.00 |
| 87802 |
|
15 |
12 |
$176.50 |
| J2060 |
Injection, lorazepam, 2 mg |
766 |
601 |
$126.55 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
258 |
215 |
$103.40 |
| 12001 |
|
47 |
38 |
$98.19 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
121 |
69 |
$65.57 |
| 87210 |
|
92 |
74 |
$65.34 |
| 80074 |
|
13 |
12 |
$46.85 |
| 87340 |
|
27 |
24 |
$36.76 |
| 87808 |
|
806 |
728 |
$35.17 |
| 85384 |
|
1,240 |
931 |
$19.79 |
| 83615 |
|
867 |
687 |
$16.67 |
| 86762 |
|
12 |
12 |
$15.82 |
| 84550 |
|
825 |
643 |
$12.28 |
| 85362 |
|
777 |
582 |
$10.89 |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
37 |
37 |
$9.28 |
| 85007 |
|
736 |
676 |
$8.37 |
| 82728 |
|
77 |
62 |
$6.68 |
| 86592 |
|
37 |
26 |
$6.61 |
| 84156 |
|
48 |
39 |
$4.79 |
| 83540 |
|
75 |
63 |
$3.36 |
| 85045 |
|
70 |
57 |
$1.76 |
| C1757 |
Catheter, thrombectomy/embolectomy |
19 |
14 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
83 |
43 |
$0.00 |
| 82805 |
|
28 |
24 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
113 |
75 |
$0.00 |
| 82375 |
|
31 |
24 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
200 |
158 |
$0.00 |
| 87899 |
|
52 |
26 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
207 |
107 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
102 |
91 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
56 |
47 |
$0.00 |
| 85461 |
|
16 |
14 |
$0.00 |
| 29105 |
|
14 |
12 |
$0.00 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
12 |
12 |
$0.00 |
| 29505 |
|
13 |
13 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
23 |
18 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
14 |
14 |
$0.00 |
| 87088 |
|
99 |
92 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
21 |
21 |
$0.00 |
| 83550 |
|
27 |
25 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
215 |
214 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
29 |
27 |
$0.00 |
| 87046 |
|
30 |
29 |
$0.00 |
| 36430 |
|
30 |
25 |
$0.00 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
39 |
28 |
$0.00 |
| J1741 |
Injection, ibuprofen, 100 mg |
34 |
27 |
$0.00 |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
21 |
20 |
$0.00 |
| 82575 |
|
13 |
13 |
$0.00 |